BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/30/2025 7:25:49 AM | Browse: 30 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 105712
Country China
Category Oncology
Manuscript Type Minireviews
Article Title Progress in the treatment of duodenal cancer: A comprehensive review
Manuscript Source Unsolicited Manuscript
All Author List Liang-Gong Liao, Zhi-Guo Xiong and Jun-Jie Hu
Funding Agency and Grant Number
Funding Agency Grant Number
Research Projects of Biomedical Center of Hubei Cancer Hospital 2022SWZX07
the 2023-2024 Annual Scientific Research Project of Traditional Chinese Medicine from Hubei Provincial Administration of Traditional Chinese Medicine ZY2023Z005
Health Commission of Hubei Province Scientific Research Project WJ2023Z011
Corresponding Author Jun-Jie Hu, MD, Department of Gastrointestinal Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 116 Zuodaoquan South Road, Wuhan 430079, Hubei Province, China. 791462122@qq.com
Key Words Duodenal cancer; Surgical resection; Chemotherapy; Targeted therapies; Immunotherapy
Core Tip Duodenal cancer, a rare gastrointestinal malignancy (< 0.5/100000 incidence), requires multidisciplinary strategies. Endoscopic resection for early-stage tumors improves survival and reduces infection mortality. Advanced cases benefit from surgery and minimally invasive techniques. Chemotherapy and neoadjuvant chemoradiotherapy enhance outcomes. Targeted therapies such as erb-b2 receptor tyrosine kinase 2 (human epidermal growth factor receptor 2)/phosphatidylinositol-3-kinase inhibitors and immunotherapy show transformative potential. Molecular profiling guides precision medicine. International collaboration is critical to optimize biomarker-driven strategies and improve survival. This review integrates innovations in surgery, systemic therapy, and immunotherapy, offering a roadmap for personalized management.
Citation Liao LG, Xiong ZG, Hu JJ. Progress in the treatment of duodenal cancer: A comprehensive review. World J Gastrointest Oncol 2025; In press
Received
2025-02-05 04:39
Peer-Review Started
2025-02-05 04:39
To Make the First Decision
Return for Revision
2025-03-25 07:10
Revised
2025-04-04 08:55
Second Decision
2025-05-30 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-05-30 07:25
Articles in Press
2025-05-30 07:25
Publication Fee Transferred
2025-04-11 04:31
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com